Skip to main content

Table 3 Univariate and multivariate analyses used for differentiating significant predictors to distinguish AFP-NHCC from healthy controls

From: Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma

Variables

Univariate analysis

Multivariate analysis

OR

95% CI

P-value

OR

95% CI

p-value

Gender

0.588

0.312–1.106

0.099

   

Age(y)

1.013

0.992–1.035

0.232

   

TBIL

1.086

1.039–1.134

< 0.001

1.110

0.985–1.250

0.086

AST

1.232

1.175–1.293

< 0.001

1.079

0.969–1.200

0.166

ALT

1.133

1.101–1.167

< 0.001

1.081

1.011–1.157

0.023

ALP

1.023

1.013–1.033

< 0.001

0.997

0.970–1.024

0.806

FPR

2.082

1.783–2.430

< 0.001

2.320

1.824–2.949

< 0.001

GPR

1.748 × 108

2.003 × 106–1.525 × 1010

< 0.001

8.260 × 106

5.031 × 103–1.356 × 1010

< 0.001

  1. TBIL total bilirubin, ALT alanine aminotransferase, AST aspartate amino transferase, ALP alkaline phosphatase, FPR fibrinogen to pre-albumin ratio, GPR gamma-glutamyl transpeptidase to platelet ratio, CI confidence interval, OR odd ratio, AFP-NHCC alpha-fetoprotein-negative hepatocellular carcinoma